Victory Capital Management Inc. Increases Position in Select Medical Holdings Co. (NYSE:SEM)

Victory Capital Management Inc. lifted its holdings in Select Medical Holdings Co. (NYSE:SEM) by 15.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,739,361 shares of the health services provider’s stock after purchasing an additional 235,964 shares during the period. Victory Capital Management Inc.’s holdings in Select Medical were worth $40,875,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of SEM. Watershed Asset Management L.L.C. lifted its position in shares of Select Medical by 8.2% during the fourth quarter. Watershed Asset Management L.L.C. now owns 10,760 shares of the health services provider’s stock worth $253,000 after purchasing an additional 814 shares during the last quarter. Paralel Advisors LLC lifted its holdings in Select Medical by 1.1% during the 3rd quarter. Paralel Advisors LLC now owns 73,981 shares of the health services provider’s stock valued at $1,870,000 after buying an additional 836 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in Select Medical by 1.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 47,310 shares of the health services provider’s stock worth $1,112,000 after acquiring an additional 858 shares in the last quarter. Mitsubishi UFJ Trust & Banking Corp purchased a new position in shares of Select Medical during the third quarter worth approximately $29,000. Finally, GAMMA Investing LLC purchased a new stake in shares of Select Medical in the fourth quarter valued at approximately $33,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Up 10.5 %

Shares of NYSE SEM opened at $31.43 on Monday. The stock has a market capitalization of $4.09 billion, a PE ratio of 14.97, a price-to-earnings-growth ratio of 1.24 and a beta of 1.38. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 2.30. Select Medical Holdings Co. has a 12-month low of $21.28 and a 12-month high of $33.51. The stock’s fifty day simple moving average is $28.42 and its two-hundred day simple moving average is $25.95.

Select Medical (NYSE:SEM) last posted its earnings results on Friday, February 23rd. The health services provider reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.05. Select Medical had a return on equity of 18.11% and a net margin of 3.97%. The company had revenue of $1.66 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the previous year, the firm earned $0.22 earnings per share. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. As a group, analysts expect that Select Medical Holdings Co. will post 2.03 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 30th. Shareholders of record on Thursday, May 16th will be issued a $0.125 dividend. This represents a $0.50 annualized dividend and a yield of 1.59%. The ex-dividend date is Wednesday, May 15th. Select Medical’s dividend payout ratio is currently 23.81%.

Insider Activity

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the business’s stock in a transaction on Monday, April 8th. The stock was sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the transaction, the chairman now directly owns 6,689,668 shares in the company, valued at approximately $200,021,073.20. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 17.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. StockNews.com raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, March 22nd. Benchmark reaffirmed a “buy” rating and issued a $39.00 price objective on shares of Select Medical in a research note on Friday. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $34.40.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.